Mersana Therapeutics, Inc. (MRSN) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 11.01M | 3.06M | 2.75M | 16.36M | 12.6M | 2.29M | 9.24M | 10.7M | 7.7M | 10.65M | 7.8M | 14.69M | 5.57M | 4.28M | 2.04M | 11K | 11K | 11K | 11K | 11K |
| Revenue Growth % | -12.61% | 33.28% | -70.21% | 52.89% | 63.65% | -78.48% | 18.5% | -27.14% | 38.13% | 148.69% | 283.2% | 133427.27% | 50563.64% | 38845.45% | 18409.09% | 0% | 0% | -98.62% | 0% | -73.81% |
| Cost of Goods Sold | 0 | 287K | 0 | 0 | 0 | 0 | 0 | 447K | 427K | 324K | 319K | 282K | 213K | 227K | 205K | 0 | 0 | 0 | 0 | 22.86M |
| COGS % of Revenue | - | 9.39% | - | - | - | - | - | 4.18% | 5.55% | 3.04% | 4.09% | 1.92% | 3.82% | 5.3% | 10.07% | - | - | - | - | 207790.91% |
| Gross Profit | 11.01M | 2.77M | 2.75M | 16.36M | 12.6M | 2.29M | 9.24M | 10.25M | 7.27M | 10.33M | 7.48M | 14.41M | 5.36M | 4.06M | 1.83M | 11K | 11K | 11K | 11K | -22.85M |
| Gross Margin % | 100% | 90.61% | 100% | 100% | 100% | 100% | 100% | 95.82% | 94.45% | 96.96% | 95.91% | 98.08% | 96.18% | 94.7% | 89.93% | 100% | 100% | 100% | 100% | -207690.91% |
| Gross Profit Growth % | -12.61% | 20.76% | -70.21% | 59.56% | 73.26% | -77.8% | 23.55% | -28.82% | 35.65% | 154.62% | 308.68% | 130863.64% | 48627.27% | 36781.82% | 16545.45% | 100.05% | 0% | -98.62% | 0% | -54495.24% |
| Operating Expenses | 18.48M | 23.35M | 27.27M | 31.17M | 24.67M | 27.75M | 30.25M | 31.18M | 43M | 66.83M | 65.28M | 60.23M | 65M | 55.81M | 48.38M | 48.04M | 45.4M | 40.84M | 34.62M | 28.77M |
| OpEx % of Revenue | 167.91% | 763.94% | 990.05% | 190.53% | 195.8% | 1210.12% | 327.16% | 291.39% | 558.56% | 627.29% | 836.76% | 410.08% | 1166.32% | 1302.68% | 2376.38% | 436745.45% | 412718.18% | 371254.55% | 314754.55% | 261554.55% |
| Selling, General & Admin | 6.3M | 7.42M | 8.93M | 8.89M | 9.86M | 10.5M | 11.56M | 9.69M | 12.47M | 18.19M | 18.33M | 14.8M | 14.57M | 14.8M | 12.78M | 10.67M | 10.12M | 8.88M | 7.21M | 5.91M |
| SG&A % of Revenue | 57.25% | 242.64% | 324.07% | 54.31% | 78.3% | 458.05% | 125.04% | 90.52% | 161.95% | 170.71% | 234.91% | 100.8% | 261.49% | 345.54% | 627.8% | 97036.36% | 92036.36% | 80754.55% | 65527.27% | 53763.64% |
| Research & Development | 12.18M | 16.22M | 18.34M | 22.29M | 14.8M | 17.25M | 18.69M | 21.5M | 30.53M | 48.64M | 46.96M | 45.43M | 50.43M | 41M | 35.6M | 37.37M | 35.27M | 31.95M | 27.41M | 22.86M |
| R&D % of Revenue | 110.65% | 530.69% | 665.98% | 136.21% | 117.5% | 752.07% | 202.12% | 200.87% | 396.61% | 456.58% | 601.85% | 309.28% | 904.83% | 957.14% | 1748.58% | 339709.09% | 320681.82% | 290500% | 249227.27% | 207790.91% |
| Other Operating Expenses | 0 | -287K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.48M | -20.58M | -24.51M | -14.81M | -12.07M | -25.45M | -21M | -20.93M | -35.73M | -56.5M | -57.8M | -45.83M | -59.64M | -51.75M | -46.55M | -48.03M | -45.39M | -40.83M | -34.61M | -51.62M |
| Operating Margin % | -67.91% | -673.33% | -890.05% | -90.53% | -95.8% | -1110.12% | -227.16% | -195.57% | -464.11% | -530.33% | -740.85% | -312% | -1070.14% | -1207.98% | -2286.44% | -436645.45% | -412618.18% | -371154.55% | -314654.55% | -469245.45% |
| Operating Income Growth % | 38.06% | 19.16% | -16.72% | 29.23% | 66.22% | 54.95% | 63.67% | 54.33% | 40.09% | -9.18% | -24.16% | 4.59% | -31.4% | -26.75% | -34.5% | 6.95% | -102.48% | -106.32% | -101.89% | -210.96% |
| EBITDA | -7.39M | -20.29M | -24.2M | -14.41M | -11.67M | -25.05M | -20.58M | -20.48M | -35.3M | -56.18M | -57.48M | -45.54M | -59.43M | -51.52M | -46.35M | -47.82M | -45.18M | -40.62M | -34.39M | -51.36M |
| EBITDA Margin % | -67.15% | -663.94% | -878.58% | -88.08% | -92.61% | -1092.54% | -222.59% | -191.39% | -458.56% | -527.29% | -736.76% | -310.08% | -1066.32% | -1202.68% | -2276.38% | -434727.27% | -410690.91% | -369281.82% | -312600% | -466881.82% |
| EBITDA Growth % | 36.63% | 19.01% | -17.58% | 29.64% | 66.95% | 55.41% | 64.2% | 55.03% | 40.6% | -9.03% | -24.03% | 4.76% | -31.54% | -26.84% | -34.78% | 6.89% | -103.86% | -107.87% | -103.52% | -214.75% |
| D&A (Non-Cash Add-back) | 83K | 287K | 316K | 400K | 402K | 403K | 423K | 447K | 427K | 324K | 319K | 282K | 213K | 227K | 205K | 211K | 212K | 206K | 226K | 260K |
| EBIT | -7.15M | -23.62M | -23.35M | -13.21M | -10.1M | -23.29M | -18.3M | -18.5M | -40.64M | -53.28M | -55.18M | -43.96M | -58.93M | -51.46M | -46.53M | -48M | -45.37M | -40.82M | -34.6M | -28.76M |
| Net Interest Income | 122K | 221K | 389K | 694K | 986K | 1.19M | 1.7M | 1.88M | 2.29M | 2.19M | 1.64M | 902K | -172K | -469K | -706K | -952K | -83K | -86K | -81K | -82K |
| Interest Income | 516K | 895K | 1.16M | 1.6M | 1.97M | 2.17M | 2.7M | 2.93M | 3.3M | 3.22M | 2.62M | 1.87M | 708K | 291K | 18K | 29K | 15K | 9K | 12K | 10K |
| Interest Expense | 394K | 674K | 775K | 903K | 986K | 983K | 1M | 1.05M | 1.02M | 1.02M | 983K | 964K | 880K | 760K | 724K | 981K | 98K | 95K | 93K | 92K |
| Other Income/Expense | -69K | -3.72M | 389K | 694K | 986K | 1.19M | 1.7M | 1.38M | -5.93M | 2.19M | 1.64M | 902K | -172K | -469K | -706K | -952K | -83K | -86K | -81K | 22.77M |
| Pretax Income | -7.54M | -24.3M | -24.12M | -14.12M | -11.08M | -24.27M | -19.31M | -19.54M | -41.66M | -54.31M | -56.16M | -44.92M | -59.81M | -52.22M | -47.26M | -48.98M | -45.47M | -40.91M | -34.69M | -28.84M |
| Pretax Margin % | -68.53% | -795.03% | -875.93% | -86.28% | -87.97% | -1058.35% | -208.83% | -182.64% | -541.13% | -509.73% | -719.85% | -305.86% | -1073.23% | -1218.93% | -2321.12% | -445300% | -413372.73% | -371936.36% | -315390.91% | -262200% |
| Income Tax | 0 | 0 | 0 | 0 | 418K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | -3.77% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -7.54M | -24.3M | -24.12M | -14.12M | -11.5M | -24.27M | -19.31M | -19.54M | -41.66M | -54.31M | -56.16M | -44.92M | -59.81M | -52.22M | -47.26M | -48.98M | -45.47M | -40.91M | -34.69M | -28.84M |
| Net Margin % | -68.53% | -795.03% | -875.93% | -86.28% | -91.29% | -1058.35% | -208.83% | -182.64% | -541.13% | -509.73% | -719.85% | -305.86% | -1073.23% | -1218.93% | -2321.12% | -445300% | -413372.73% | -371936.36% | -315390.91% | -262200% |
| Net Income Growth % | 34.4% | -0.12% | -24.95% | 27.77% | 72.39% | 55.31% | 65.63% | 56.5% | 30.35% | -4% | -18.84% | 8.29% | -31.54% | -27.63% | -36.22% | -69.83% | -102.19% | -106.78% | -104.97% | -77.53% |
| Net Income (Continuing) | -7.54M | -24.3M | -24.12M | -14.12M | -11.5M | -24.27M | -19.31M | -19.54M | -41.66M | -54.31M | -56.16M | -44.92M | -59.81M | -52.22M | -47.26M | -48.98M | -45.47M | -40.91M | -34.69M | -28.84M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.51 | -4.87 | -4.85 | -2.86 | -2.34 | -4.96 | -3.97 | -4.05 | -8.64 | -11.74 | -13.06 | -11.12 | -15.31 | -13.63 | -14.78 | -17.03 | -15.84 | -14.69 | -12.57 | -10.54 |
| EPS Growth % | 35.47% | 1.81% | -22.17% | 29.38% | 72.92% | 57.75% | 69.6% | 63.58% | 43.57% | 13.87% | 11.64% | 34.7% | 3.35% | 7.22% | -17.58% | -61.58% | -92.7% | -80.47% | -42.52% | -24.29% |
| EPS (Basic) | -1.51 | -4.87 | -4.85 | -2.86 | -2.34 | -4.96 | -3.97 | -4.05 | -8.64 | -11.74 | -13.06 | -11.12 | -15.31 | -13.63 | -14.78 | -17.03 | -15.84 | -14.69 | -12.57 | -10.54 |
| Diluted Shares Outstanding | 4.99M | 4.99M | 4.98M | 4.94M | 4.91M | 4.9M | 4.86M | 4.82M | 4.82M | 4.62M | 4.3M | 4.04M | 3.91M | 3.83M | 3.2M | 2.88M | 2.87M | 2.78M | 2.76M | 2.74M |
| Basic Shares Outstanding | 4.99M | 4.99M | 4.98M | 4.94M | 4.91M | 4.9M | 4.86M | 4.82M | 4.82M | 4.62M | 4.3M | 4.04M | 3.91M | 3.83M | 3.2M | 2.88M | 2.87M | 2.78M | 2.76M | 2.74M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |